Damage to mitochondrial DNA induced by the quinolone Bay y 3118 in embryonic turkey liver

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 425, Issue 2, 1999, Pages 213-224

  Enzmann, H ^a   Wiemann, C ^b   Ahr, H J ^a   Schluter G ^a  

^a Institute of Toxicology   (Germany)

^b BASF SE   (Germany)

Author keywords

Bacterium; Mitochondrial DNA; Quinolone

Indexed keywords

8 CHLORO 1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4.3.0]NON 8 YL) 6 FLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID; DIETHYLNITROSAMINE; MITOCHONDRIAL DNA; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; EGG; EMBRYO; GENOTOXICITY; LIVER MITOCHONDRION; MUTATION; NONHUMAN; PRIORITY JOURNAL; TURKEY (BIRD);

ANIMALS; ANTI-INFECTIVE AGENTS; DNA DAMAGE; DNA, MITOCHONDRIAL; EMBRYO, NONMAMMALIAN; EXTRACHROMOSOMAL INHERITANCE; FLUOROQUINOLONES; LIVER; MUTAGENICITY TESTS; TURKEYS;

EID: 0032910579     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00044-5     Document Type: Article

References (54)

1. Allen J.A., Coombs M.M. Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature. 287:1980;244-245.
2. Ambs S., Neumann H.G. Acute and chronic toxicity of aromatic amines studied in the isolated perfused rat liver. Toxicology and Applied Pharmacology. 139:1996;186-194.
3. Backer J.M., Weinstein I.B. Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo[a]pyrene. Science. 209:1980;297-299.
4. Baggetto L.G. Role of mitochondria in carcinogenesis. European Journal of Cancer A. 29:1993;156-159.
5. Balansky R., Izzotti A., Scatolini L., D'Agostini F., De Flora S. Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs. Cancer Research. 56:1996;1642-1647.
6. Barat-Gueride M., Dufresne C., Rickwood D. Effect of DNA conformation on the transcription of mitochondrial DNA. European Journal of Biochemistry. 183:1989;297-302.
7. Barja G., Cadenas S., Rojas C., Lopez-Torres M., Perez-Campo R. A decrease of free-radical production near-critical targets as a cause of maximum longevity in animals. Comparative Biochemistry and Physiology B: Biochemistry Molecular Biology. 108:1994;501-512.
8. 2 consumption can explain the simultaneous presence of high longevity and high aerobic metabolic rate in birds. Free Radical Research. 21:1994;317-327.
9. Bremm K.D., Petersen U., Metzger K.G., Endermann R. In vitro evaluation of Bay-y 3118, a new full-spectrum fluoroquinolone. Chemotherapy. 38:1992;376-387.
10. Brunström B. Activities in chick embryos of 7-ethoxycoumarin O-deethylase and acryl hydrocarbon (benzo[a]pyrene) hydrolase and their induction by 3,3′,4,4′- tetrachlorobiphenyl in early embryos. Xenobiotics. 16:1986;865-872.
11. Clayton D.A. Replication of animal mitochondrial DNA. Cell. 28:1982;693-705.
12. Clerch B., Bravo J.M., Llagostera M.T. Analysis of the ciprofloxacin-induced mutations in salmonella typhimurium. Environmental and Molecular Mutagenesis. 27:1996;110-115.
13. Curry P.T., Kropko M.L., Garvin J.R., Fiedler R.D., Theiss J.C. In-vitro induction of micronuclei and chromosome-aberrations by quinolones - possible mechanisms. Mutation Research. 352:1996;143-150.
14. Enzmann H., Kaliner G., Watta-Gebert B., Löser E. Foci of altered hepatocytes induced in embryonic turkey liver. Carcinogenesis. 13:1992;943-946.
15. Enzmann H., Kühlem C., Kaliner G., Löser E., Bannasch P. Rapid induction of preneoplastic liver foci in embryonic turkey liver by diethylnitrosamine. Toxicologic Pathology. 23:1995;560-569.
16. Enzmann H., Kühlem C., Löser E., Bannasch P. Dose dependence of diethylnitrosamine-induced nuclear enlargement in embryonic turkey liver. Carcinogenesis. 16:1995;1351-1355.
17. Enzmann H., Kühlem C., Löser E., Bannasch P. Damage to mitochondrial DNA induced by the hepatocarcinogen diethylnitrosamine in ovo. Mutation Research. 329:1995;113-120.
18. Fraga C.G., Shigenaga M.K., Park J.W., Degan P., Ames B.N. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proceedings of the National Academy of Science of the USA. 87:1990;4533-4537.
19. Gerlach L. Über neuere Methoden auf dem Gebiet der experimentellen Embryologie. Anatomischer Anzeiger. 2:1887;583-609.
20. Giurgiovich A.J., Diwan B.A., Olivero O.A., Anderson L.M., Rice J.M., Poirier M.C. Elevated mitochondrial cisplatin-DNA adduct levels in rat tissues after transplacental cisplatin exposure. Carcinogenesis. 18:1997;93-96.
21. Gudikote J.P., Van Tuyle G.C. Rearrangements in the shorter arc of rat mitochondrial DNA involving the region of the heavy and light strand promoters. Mutation Research. 356:1996;275-286.
22. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. American Journal of Medicine. 91:1991;14S-22S.
23. Hamilton J.W., Bloom S.E. Correlation between mixed-function oxidase enzyme induction and aflatoxin B1-induced unscheduled DNA synthesis in the chick embryo in vivo. Environmental Mutagenesis. 6:1984;41-48.
24. G.G. Hatch, F.W. Edens, L.C. Rogers, B. Most, Embryotoxic, tumor and other post-hatch effects of chemical carcinogens and noncarcinogens following in ovo yolk sac inoculation of Japanese quail, in: J. Ashby, F.J. deSerres, M.D. Shelby, B.H. Margolin, M. Ishidate, G.C. Becking (Eds.) Evaluation of Short-term Test for Carcinogens, Cambridge Univ. Press, Cambridge, 1988, pp. 2.35-2.42.
25. Howell N., Kubacka I., Mackey D.A. How rapidly does the human mitochondrial genome evolve? American Journal of Human Genetics. 59:1996;501-509.
26. Johns D.R. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. New England Journal of Medicine. 333:1995;638-644.
27. Ku H.H., Sohal R.S. Comparison of mitochondrial pro-oxidant generation and anti-oxidant defenses between rat and pigeon: possible basis of variation in longevity and metabolic potential. Mechanisms of Aging and Development. 72:1993;67-76.
28. Larsson N.G., Clayton D.A. Molecular genetic aspects of human mitochondrial disorders. Annual Review of Genetics. 29:1995;151-178.
29. Lawrence J.W., Claire D.C., Weissig V., Rowe T.C. Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells. Molecular Pharmacology. 50:1996;1178-1188.
30. Lawrence J.W., Darkinrattray S., Xie F., Neims A.H., Rowe T.C. 4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells. Journal of Cellular Biochemistry. 51:1993;165-174.
31. LeDoux S.P., Wilson G.L., Beecham E.J., Stevnsner T., Wassermann K., Bohr V.A. Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis. 13:1992;1967-1973.
32. Machala M., Nezveda K., Irizar A., Bu-Abas A., Ioannides C. Expression and inducability of cytochrome p450 proteins in the liver of chick embryo. Archives of Toxicology. 71:1996;57-63.
33. McClellan R.A., Drobitch R.K., Monshouwer M., Renton K.W. Fluoroquinolone antibiotics inhibit cytochrome p450-mediated microsomal drug-metabolism in rat and human. Drug Metabolism and Disposition. 24:1996;1134-1138.
34. Melov S., Minerfeld D., Esposito L., Wallace D.C. Multi-organ characterization of mitochondrial genomic rearrangements in ad libitum and caloric restricted mice show striking somatic mitochondrial DNA rearrangements with age. Nucleic Acids Research. 25:1997;974-982.
35. Obernauerova M., Subik J. Energy-dependent mitochondrial mutagenicity of antibacterial ofloxacin and its recombinogenic activity in yeast. Current Genetics. 26:1994;281-284.
36. Ozawa T. Mechanism of somatic mitochondrial DNA mutations associated with age and diseases. Biochimica et Biophysica Acta. 1271:1995;177-189.
37. 32P -postlabeling: relationships to cancer and aging Experimental Gerontology. 27:1992;533-549.
38. Richter C. Reactive oxygen and DNA damage in mitochondria. Mutation Research. 275:1992;249-255.
39. Rosen J.E., Schlueter G., Williams G.M. Lack of effects of ciprofloxacin and the topoisomerase-II inhibitors m-AMSA and nalidixic-acid on DNA-repair in cultured rat liver cells. Toxicology and Applied Pharmacology. 140:1996;254-263.
40. Saran M., Bors W. Radical reactions in vivo - an overview. Radiation and Environmental Biophysics. 29:1990;249-262.
41. Schulz T.G., Stahlmann R., Edwards R.J., Debri K., Davies D.S., Neubert D. Enoxacin is an inducer of CYP1A2 in rat liver. Biochemical Pharmacology. 50:1995;1517-1520.
42. Shadel G.S., Clayton D.A. Mitochondrial DNA maintenance in vertebrates. Annual Review of Biochemistry. 66:1997;409-435.
43. Shen C.C., Wertelecki W., Driggers W.J., LeDoux S.P., Wilson G.L. Repair of mitochondrial DNA damage induced by bleomycin in human cells. Mutation Research. 337:1995;19-23.
44. Singh G., Maniccia-Bozzo E. Evidence for lack of mitochondrial DNA repair following cis-dichlorodiammineplatinum treatment. Cancer Chemotherapy and Pharmacology. 26:1990;97-100.
45. Singh G., Sharkey S.M., Moorehead R. Mitochondrial DNA damage by anticancer agents. Pharmacology and Therapeutics. 54:1992;217-230.
46. Tempel K.H., Ignatius A., Hund M. DNA damage and repair in chick embryo cells following X-irradiation in vitro as compared to mammalian cells - biochemical and physicochemical investigations. Radiation and Environmental Biophysics. 31:1992;91-100.
47. Tempel K.H., Ignatius A., Stammberger I. A short-term test for nucleotoxicity that uses chick embryo cells treated in vitro and in vivo - physicochemical and biochemical investigations. Comparative Biochemistry and Physiology C: Comparative Pharmacology and Toxicology. 103:1992;73-78.
48. Tempel K.H., Schleifer S. Adaptive response of the chicken embryo to low doses of X-irradiation. Radiation and Environmental Biophysics. 34:1995;117-183.
49. Walker U.A., Jean-Francois B., Byrne E. Impact of the 25th chromosome on mitochondrial dysfunction in human disease. Journal of Clinical Neuroscience. 2:1995;107-117.
50. Wallace D.C. Mitochondrial genetics: A paradigm for aging and degenerative diseases. Science. 256:1992;628-632.
51. Welter C., Dooley D., Blin N. A rapid protocol for the purification of mitochondrial DNA suitable for studying restriction fragment length polymorphism. Gene. 83:1989;169-172.
52. Williams G.M., Whysner J. Epigenetic carcinogenesis, evaluation and risk assessment. Experimental and Toxicologic Pathology. 48:1996;189-195.
53. Zerban H., Radig S., Kopp-Schneider A., Bannasch P. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotype cellular diversity and instability. Carcinogenesis. 15:1994;2467-2473.
54. Short C.R., Flory W., Hsieh L.C., Aranas T., Ou S.P., Weissinger J. Comparison of hepatic drug metabolizing enzyme activities in several agricultural species. Comp. Biochem. Physiol. 91:1988;419-422.